The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Recombinant Humanized Collagen Market Research Report 2025
Synopsis
Recombinant human collagen is a genetically engineered strain constructed by molecular biology method. The collagen type III was purified by more than a dozen separation process. The product is sterilized under GMP conditions and lyophilized to obtain active product.
The global Recombinant Humanized Collagen market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Recombinant Humanized Collagen is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Recombinant Humanized Collagen is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Recombinant Humanized Collagen include ACROBiosystems, FineTest, Evonik, Giant Biogene, Shanxi Jinbo Bio-Pharmaceutical, Jiangsu JLand Biotech, Jiangsu Chuangjian Medical Technology and JY-RAN, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Recombinant Humanized Collagen, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Humanized Collagen.
Report Scope
The Recombinant Humanized Collagen market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Recombinant Humanized Collagen market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Humanized Collagen manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ACROBiosystems
FineTest
Evonik
Giant Biogene
Shanxi Jinbo Bio-Pharmaceutical
Jiangsu JLand Biotech
Jiangsu Chuangjian Medical Technology
JY-RAN
Segment by Type
Type I Collagen
Type Ⅲ Collagen
Others
Segment by Application
Food Health Care
Beauty Cosmetics
Biomedical Materials
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant Humanized Collagen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Recombinant Humanized Collagen in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Recombinant human collagen is a genetically engineered strain constructed by molecular biology method. The collagen type III was purified by more than a dozen separation process. The product is sterilized under GMP conditions and lyophilized to obtain active product.
The global Recombinant Humanized Collagen market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Recombinant Humanized Collagen is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Recombinant Humanized Collagen is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Recombinant Humanized Collagen include ACROBiosystems, FineTest, Evonik, Giant Biogene, Shanxi Jinbo Bio-Pharmaceutical, Jiangsu JLand Biotech, Jiangsu Chuangjian Medical Technology and JY-RAN, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Recombinant Humanized Collagen, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Humanized Collagen.
Report Scope
The Recombinant Humanized Collagen market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Recombinant Humanized Collagen market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Humanized Collagen manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ACROBiosystems
FineTest
Evonik
Giant Biogene
Shanxi Jinbo Bio-Pharmaceutical
Jiangsu JLand Biotech
Jiangsu Chuangjian Medical Technology
JY-RAN
Segment by Type
Type I Collagen
Type Ⅲ Collagen
Others
Segment by Application
Food Health Care
Beauty Cosmetics
Biomedical Materials
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant Humanized Collagen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Recombinant Humanized Collagen in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Recombinant Humanized Collagen Market Overview
1.1 Product Overview and Scope of Recombinant Humanized Collagen
1.2 Recombinant Humanized Collagen Segment by Type
1.2.1 Global Recombinant Humanized Collagen Market Value Comparison by Type (2024-2030)
1.2.2 Type I Collagen
1.2.3 Type Ⅲ Collagen
1.2.4 Others
1.3 Recombinant Humanized Collagen Segment by Application
1.3.1 Global Recombinant Humanized Collagen Market Value by Application: (2024-2030)
1.3.2 Food Health Care
1.3.3 Beauty Cosmetics
1.3.4 Biomedical Materials
1.4 Global Recombinant Humanized Collagen Market Size Estimates and Forecasts
1.4.1 Global Recombinant Humanized Collagen Revenue 2019-2030
1.4.2 Global Recombinant Humanized Collagen Sales 2019-2030
1.4.3 Global Recombinant Humanized Collagen Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Recombinant Humanized Collagen Market Competition by Manufacturers
2.1 Global Recombinant Humanized Collagen Sales Market Share by Manufacturers (2019-2024)
2.2 Global Recombinant Humanized Collagen Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Recombinant Humanized Collagen Average Price by Manufacturers (2019-2024)
2.4 Global Recombinant Humanized Collagen Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Humanized Collagen, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Humanized Collagen, Product Type & Application
2.7 Recombinant Humanized Collagen Market Competitive Situation and Trends
2.7.1 Recombinant Humanized Collagen Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Recombinant Humanized Collagen Players Market Share by Revenue
2.7.3 Global Recombinant Humanized Collagen Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Recombinant Humanized Collagen Retrospective Market Scenario by Region
3.1 Global Recombinant Humanized Collagen Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Recombinant Humanized Collagen Global Recombinant Humanized Collagen Sales by Region: 2019-2030
3.2.1 Global Recombinant Humanized Collagen Sales by Region: 2019-2024
3.2.2 Global Recombinant Humanized Collagen Sales by Region: 2025-2030
3.3 Global Recombinant Humanized Collagen Global Recombinant Humanized Collagen Revenue by Region: 2019-2030
3.3.1 Global Recombinant Humanized Collagen Revenue by Region: 2019-2024
3.3.2 Global Recombinant Humanized Collagen Revenue by Region: 2025-2030
3.4 North America Recombinant Humanized Collagen Market Facts & Figures by Country
3.4.1 North America Recombinant Humanized Collagen Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Recombinant Humanized Collagen Sales by Country (2019-2030)
3.4.3 North America Recombinant Humanized Collagen Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant Humanized Collagen Market Facts & Figures by Country
3.5.1 Europe Recombinant Humanized Collagen Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Recombinant Humanized Collagen Sales by Country (2019-2030)
3.5.3 Europe Recombinant Humanized Collagen Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Humanized Collagen Market Facts & Figures by Country
3.6.1 Asia Pacific Recombinant Humanized Collagen Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Recombinant Humanized Collagen Sales by Country (2019-2030)
3.6.3 Asia Pacific Recombinant Humanized Collagen Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Recombinant Humanized Collagen Market Facts & Figures by Country
3.7.1 Latin America Recombinant Humanized Collagen Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Recombinant Humanized Collagen Sales by Country (2019-2030)
3.7.3 Latin America Recombinant Humanized Collagen Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Recombinant Humanized Collagen Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Humanized Collagen Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Recombinant Humanized Collagen Sales by Country (2019-2030)
3.8.3 Middle East and Africa Recombinant Humanized Collagen Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Humanized Collagen Sales by Type (2019-2030)
4.1.1 Global Recombinant Humanized Collagen Sales by Type (2019-2024)
4.1.2 Global Recombinant Humanized Collagen Sales by Type (2025-2030)
4.1.3 Global Recombinant Humanized Collagen Sales Market Share by Type (2019-2030)
4.2 Global Recombinant Humanized Collagen Revenue by Type (2019-2030)
4.2.1 Global Recombinant Humanized Collagen Revenue by Type (2019-2024)
4.2.2 Global Recombinant Humanized Collagen Revenue by Type (2025-2030)
4.2.3 Global Recombinant Humanized Collagen Revenue Market Share by Type (2019-2030)
4.3 Global Recombinant Humanized Collagen Price by Type (2019-2030)
5 Segment by Application
5.1 Global Recombinant Humanized Collagen Sales by Application (2019-2030)
5.1.1 Global Recombinant Humanized Collagen Sales by Application (2019-2024)
5.1.2 Global Recombinant Humanized Collagen Sales by Application (2025-2030)
5.1.3 Global Recombinant Humanized Collagen Sales Market Share by Application (2019-2030)
5.2 Global Recombinant Humanized Collagen Revenue by Application (2019-2030)
5.2.1 Global Recombinant Humanized Collagen Revenue by Application (2019-2024)
5.2.2 Global Recombinant Humanized Collagen Revenue by Application (2025-2030)
5.2.3 Global Recombinant Humanized Collagen Revenue Market Share by Application (2019-2030)
5.3 Global Recombinant Humanized Collagen Price by Application (2019-2030)
6 Key Companies Profiled
6.1 ACROBiosystems
6.1.1 ACROBiosystems Corporation Information
6.1.2 ACROBiosystems Description and Business Overview
6.1.3 ACROBiosystems Recombinant Humanized Collagen Sales, Revenue and Gross Margin (2019-2024)
6.1.4 ACROBiosystems Recombinant Humanized Collagen Product Portfolio
6.1.5 ACROBiosystems Recent Developments/Updates
6.2 FineTest
6.2.1 FineTest Corporation Information
6.2.2 FineTest Description and Business Overview
6.2.3 FineTest Recombinant Humanized Collagen Sales, Revenue and Gross Margin (2019-2024)
6.2.4 FineTest Recombinant Humanized Collagen Product Portfolio
6.2.5 FineTest Recent Developments/Updates
6.3 Evonik
6.3.1 Evonik Corporation Information
6.3.2 Evonik Description and Business Overview
6.3.3 Evonik Recombinant Humanized Collagen Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Evonik Recombinant Humanized Collagen Product Portfolio
6.3.5 Evonik Recent Developments/Updates
6.4 Giant Biogene
6.4.1 Giant Biogene Corporation Information
6.4.2 Giant Biogene Description and Business Overview
6.4.3 Giant Biogene Recombinant Humanized Collagen Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Giant Biogene Recombinant Humanized Collagen Product Portfolio
6.4.5 Giant Biogene Recent Developments/Updates
6.5 Shanxi Jinbo Bio-Pharmaceutical
6.5.1 Shanxi Jinbo Bio-Pharmaceutical Corporation Information
6.5.2 Shanxi Jinbo Bio-Pharmaceutical Description and Business Overview
6.5.3 Shanxi Jinbo Bio-Pharmaceutical Recombinant Humanized Collagen Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Shanxi Jinbo Bio-Pharmaceutical Recombinant Humanized Collagen Product Portfolio
6.5.5 Shanxi Jinbo Bio-Pharmaceutical Recent Developments/Updates
6.6 Jiangsu JLand Biotech
6.6.1 Jiangsu JLand Biotech Corporation Information
6.6.2 Jiangsu JLand Biotech Description and Business Overview
6.6.3 Jiangsu JLand Biotech Recombinant Humanized Collagen Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Jiangsu JLand Biotech Recombinant Humanized Collagen Product Portfolio
6.6.5 Jiangsu JLand Biotech Recent Developments/Updates
6.7 Jiangsu Chuangjian Medical Technology
6.6.1 Jiangsu Chuangjian Medical Technology Corporation Information
6.6.2 Jiangsu Chuangjian Medical Technology Description and Business Overview
6.6.3 Jiangsu Chuangjian Medical Technology Recombinant Humanized Collagen Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Jiangsu Chuangjian Medical Technology Recombinant Humanized Collagen Product Portfolio
6.7.5 Jiangsu Chuangjian Medical Technology Recent Developments/Updates
6.8 JY-RAN
6.8.1 JY-RAN Corporation Information
6.8.2 JY-RAN Description and Business Overview
6.8.3 JY-RAN Recombinant Humanized Collagen Sales, Revenue and Gross Margin (2019-2024)
6.8.4 JY-RAN Recombinant Humanized Collagen Product Portfolio
6.8.5 JY-RAN Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Humanized Collagen Industry Chain Analysis
7.2 Recombinant Humanized Collagen Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Humanized Collagen Production Mode & Process
7.4 Recombinant Humanized Collagen Sales and Marketing
7.4.1 Recombinant Humanized Collagen Sales Channels
7.4.2 Recombinant Humanized Collagen Distributors
7.5 Recombinant Humanized Collagen Customers
8 Recombinant Humanized Collagen Market Dynamics
8.1 Recombinant Humanized Collagen Industry Trends
8.2 Recombinant Humanized Collagen Market Drivers
8.3 Recombinant Humanized Collagen Market Challenges
8.4 Recombinant Humanized Collagen Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Recombinant Humanized Collagen Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Recombinant Humanized Collagen Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Recombinant Humanized Collagen Market Competitive Situation by Manufacturers in 2023
Table 4. Global Recombinant Humanized Collagen Sales (MT) of Key Manufacturers (2019-2024)
Table 5. Global Recombinant Humanized Collagen Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Recombinant Humanized Collagen Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Recombinant Humanized Collagen Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Recombinant Humanized Collagen Average Price (USD/Kg) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Recombinant Humanized Collagen, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Recombinant Humanized Collagen, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Recombinant Humanized Collagen, Product Type & Application
Table 12. Global Key Manufacturers of Recombinant Humanized Collagen, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Recombinant Humanized Collagen by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Humanized Collagen as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Recombinant Humanized Collagen Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Recombinant Humanized Collagen Sales by Region (2019-2024) & (MT)
Table 18. Global Recombinant Humanized Collagen Sales Market Share by Region (2019-2024)
Table 19. Global Recombinant Humanized Collagen Sales by Region (2025-2030) & (MT)
Table 20. Global Recombinant Humanized Collagen Sales Market Share by Region (2025-2030)
Table 21. Global Recombinant Humanized Collagen Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Recombinant Humanized Collagen Revenue Market Share by Region (2019-2024)
Table 23. Global Recombinant Humanized Collagen Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Recombinant Humanized Collagen Revenue Market Share by Region (2025-2030)
Table 25. North America Recombinant Humanized Collagen Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Recombinant Humanized Collagen Sales by Country (2019-2024) & (MT)
Table 27. North America Recombinant Humanized Collagen Sales by Country (2025-2030) & (MT)
Table 28. North America Recombinant Humanized Collagen Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Recombinant Humanized Collagen Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Recombinant Humanized Collagen Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Recombinant Humanized Collagen Sales by Country (2019-2024) & (MT)
Table 32. Europe Recombinant Humanized Collagen Sales by Country (2025-2030) & (MT)
Table 33. Europe Recombinant Humanized Collagen Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Recombinant Humanized Collagen Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Recombinant Humanized Collagen Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Recombinant Humanized Collagen Sales by Region (2019-2024) & (MT)
Table 37. Asia Pacific Recombinant Humanized Collagen Sales by Region (2025-2030) & (MT)
Table 38. Asia Pacific Recombinant Humanized Collagen Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Recombinant Humanized Collagen Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Recombinant Humanized Collagen Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Recombinant Humanized Collagen Sales by Country (2019-2024) & (MT)
Table 42. Latin America Recombinant Humanized Collagen Sales by Country (2025-2030) & (MT)
Table 43. Latin America Recombinant Humanized Collagen Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Recombinant Humanized Collagen Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Recombinant Humanized Collagen Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Recombinant Humanized Collagen Sales by Country (2019-2024) & (MT)
Table 47. Middle East & Africa Recombinant Humanized Collagen Sales by Country (2025-2030) & (MT)
Table 48. Middle East & Africa Recombinant Humanized Collagen Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Recombinant Humanized Collagen Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Recombinant Humanized Collagen Sales (MT) by Type (2019-2024)
Table 51. Global Recombinant Humanized Collagen Sales (MT) by Type (2025-2030)
Table 52. Global Recombinant Humanized Collagen Sales Market Share by Type (2019-2024)
Table 53. Global Recombinant Humanized Collagen Sales Market Share by Type (2025-2030)
Table 54. Global Recombinant Humanized Collagen Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Recombinant Humanized Collagen Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Recombinant Humanized Collagen Revenue Market Share by Type (2019-2024)
Table 57. Global Recombinant Humanized Collagen Revenue Market Share by Type (2025-2030)
Table 58. Global Recombinant Humanized Collagen Price (USD/Kg) by Type (2019-2024)
Table 59. Global Recombinant Humanized Collagen Price (USD/Kg) by Type (2025-2030)
Table 60. Global Recombinant Humanized Collagen Sales (MT) by Application (2019-2024)
Table 61. Global Recombinant Humanized Collagen Sales (MT) by Application (2025-2030)
Table 62. Global Recombinant Humanized Collagen Sales Market Share by Application (2019-2024)
Table 63. Global Recombinant Humanized Collagen Sales Market Share by Application (2025-2030)
Table 64. Global Recombinant Humanized Collagen Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Recombinant Humanized Collagen Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Recombinant Humanized Collagen Revenue Market Share by Application (2019-2024)
Table 67. Global Recombinant Humanized Collagen Revenue Market Share by Application (2025-2030)
Table 68. Global Recombinant Humanized Collagen Price (USD/Kg) by Application (2019-2024)
Table 69. Global Recombinant Humanized Collagen Price (USD/Kg) by Application (2025-2030)
Table 70. ACROBiosystems Corporation Information
Table 71. ACROBiosystems Description and Business Overview
Table 72. ACROBiosystems Recombinant Humanized Collagen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 73. ACROBiosystems Recombinant Humanized Collagen Product
Table 74. ACROBiosystems Recent Developments/Updates
Table 75. FineTest Corporation Information
Table 76. FineTest Description and Business Overview
Table 77. FineTest Recombinant Humanized Collagen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 78. FineTest Recombinant Humanized Collagen Product
Table 79. FineTest Recent Developments/Updates
Table 80. Evonik Corporation Information
Table 81. Evonik Description and Business Overview
Table 82. Evonik Recombinant Humanized Collagen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 83. Evonik Recombinant Humanized Collagen Product
Table 84. Evonik Recent Developments/Updates
Table 85. Giant Biogene Corporation Information
Table 86. Giant Biogene Description and Business Overview
Table 87. Giant Biogene Recombinant Humanized Collagen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 88. Giant Biogene Recombinant Humanized Collagen Product
Table 89. Giant Biogene Recent Developments/Updates
Table 90. Shanxi Jinbo Bio-Pharmaceutical Corporation Information
Table 91. Shanxi Jinbo Bio-Pharmaceutical Description and Business Overview
Table 92. Shanxi Jinbo Bio-Pharmaceutical Recombinant Humanized Collagen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 93. Shanxi Jinbo Bio-Pharmaceutical Recombinant Humanized Collagen Product
Table 94. Shanxi Jinbo Bio-Pharmaceutical Recent Developments/Updates
Table 95. Jiangsu JLand Biotech Corporation Information
Table 96. Jiangsu JLand Biotech Description and Business Overview
Table 97. Jiangsu JLand Biotech Recombinant Humanized Collagen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 98. Jiangsu JLand Biotech Recombinant Humanized Collagen Product
Table 99. Jiangsu JLand Biotech Recent Developments/Updates
Table 100. Jiangsu Chuangjian Medical Technology Corporation Information
Table 101. Jiangsu Chuangjian Medical Technology Description and Business Overview
Table 102. Jiangsu Chuangjian Medical Technology Recombinant Humanized Collagen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 103. Jiangsu Chuangjian Medical Technology Recombinant Humanized Collagen Product
Table 104. Jiangsu Chuangjian Medical Technology Recent Developments/Updates
Table 105. JY-RAN Corporation Information
Table 106. JY-RAN Description and Business Overview
Table 107. JY-RAN Recombinant Humanized Collagen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 108. JY-RAN Recombinant Humanized Collagen Product
Table 109. JY-RAN Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Recombinant Humanized Collagen Distributors List
Table 113. Recombinant Humanized Collagen Customers List
Table 114. Recombinant Humanized Collagen Market Trends
Table 115. Recombinant Humanized Collagen Market Drivers
Table 116. Recombinant Humanized Collagen Market Challenges
Table 117. Recombinant Humanized Collagen Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Recombinant Humanized Collagen
Figure 2. Global Recombinant Humanized Collagen Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Recombinant Humanized Collagen Market Share by Type in 2023 & 2030
Figure 4. Type I Collagen Product Picture
Figure 5. Type Ⅲ Collagen Product Picture
Figure 6. Others Product Picture
Figure 7. Global Recombinant Humanized Collagen Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Recombinant Humanized Collagen Market Share by Application in 2023 & 2030
Figure 9. Food Health Care
Figure 10. Beauty Cosmetics
Figure 11. Biomedical Materials
Figure 12. Global Recombinant Humanized Collagen Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Recombinant Humanized Collagen Market Size (2019-2030) & (US$ Million)
Figure 14. Global Recombinant Humanized Collagen Sales (2019-2030) & (MT)
Figure 15. Global Recombinant Humanized Collagen Average Price (USD/Kg) & (2019-2030)
Figure 16. Recombinant Humanized Collagen Report Years Considered
Figure 17. Recombinant Humanized Collagen Sales Share by Manufacturers in 2023
Figure 18. Global Recombinant Humanized Collagen Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Recombinant Humanized Collagen Players: Market Share by Revenue in 2023
Figure 20. Recombinant Humanized Collagen Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Recombinant Humanized Collagen Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Recombinant Humanized Collagen Sales Market Share by Country (2019-2030)
Figure 23. North America Recombinant Humanized Collagen Revenue Market Share by Country (2019-2030)
Figure 24. United States Recombinant Humanized Collagen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Recombinant Humanized Collagen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Recombinant Humanized Collagen Sales Market Share by Country (2019-2030)
Figure 27. Europe Recombinant Humanized Collagen Revenue Market Share by Country (2019-2030)
Figure 28. Germany Recombinant Humanized Collagen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Recombinant Humanized Collagen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Recombinant Humanized Collagen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Recombinant Humanized Collagen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Recombinant Humanized Collagen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Recombinant Humanized Collagen Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Recombinant Humanized Collagen Revenue Market Share by Region (2019-2030)
Figure 35. China Recombinant Humanized Collagen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Recombinant Humanized Collagen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Recombinant Humanized Collagen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Recombinant Humanized Collagen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Recombinant Humanized Collagen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Recombinant Humanized Collagen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Recombinant Humanized Collagen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Recombinant Humanized Collagen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Recombinant Humanized Collagen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Recombinant Humanized Collagen Sales Market Share by Country (2019-2030)
Figure 45. Latin America Recombinant Humanized Collagen Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Recombinant Humanized Collagen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Recombinant Humanized Collagen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Recombinant Humanized Collagen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Recombinant Humanized Collagen Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Recombinant Humanized Collagen Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Recombinant Humanized Collagen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Recombinant Humanized Collagen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Recombinant Humanized Collagen Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Recombinant Humanized Collagen by Type (2019-2030)
Figure 55. Global Revenue Market Share of Recombinant Humanized Collagen by Type (2019-2030)
Figure 56. Global Recombinant Humanized Collagen Price (USD/Kg) by Type (2019-2030)
Figure 57. Global Sales Market Share of Recombinant Humanized Collagen by Application (2019-2030)
Figure 58. Global Revenue Market Share of Recombinant Humanized Collagen by Application (2019-2030)
Figure 59. Global Recombinant Humanized Collagen Price (USD/Kg) by Application (2019-2030)
Figure 60. Recombinant Humanized Collagen Value Chain
Figure 61. Recombinant Humanized Collagen Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
